Chemiluminescence imaging shows improved performance in deep tumor imaging, suggesting better outcomes than traditional fluorescence probes.
Chemiluminescence (CL) imaging offers unique advantages over fluorescence (FL) imaging, including excitation-free operation, low background interference, and strong tissue penetration. However, current carbon dot (CD)-based CL systems still suffer from short emission wavelengths, limited signal duration, and insufficient brightness, which severely hinder their applications in deep-tissue imaging. In this work, we present a novel design strategy that leverages the persistent afterglow effect of CDs to construct a self-sustained, long-lasting CL system. Near-infrared emissive carbon dots (LKCDs) were synthesized through a green approach, exhibiting a sharp emission peak at 672 nm with a narrow full width at half-maximum of 34 nm, a high fluorescence quantum yield of 18.3%, and an afterglow lifetime over 31 min. By coassembling LKCDs with CPPO in Pluronic F-127 micelles, we developed hydrogen peroxide-responsive CL nanoprobe (LCF-NPs), in which the chemically initiated electron-exchange luminescence (CIEEL) process is coupled with the intrinsic afterglow of LKCDs to achieve persistent CL emission. In vivo experiments with 4T1 tumor-bearing mice demonstrated that LCF-NPs produced stable NIR CL signal at tumor site for over 12 h, substantially outperforming traditional fluorescence probes. This study not only establishes an efficient long-lasting NIR CL imaging platform but also provides methodological insights for designing persistent CL systems in bioanalytical applications.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: